Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 47
Filter
1.
Cell ; 172(5): 1079-1090.e12, 2018 02 22.
Article in English | MEDLINE | ID: mdl-29474908

ABSTRACT

How signaling dynamics encode information is a central question in biology. During vertebrate development, dynamic Notch signaling oscillations control segmentation of the presomitic mesoderm (PSM). In mouse embryos, this molecular clock comprises signaling oscillations of several pathways, i.e., Notch, Wnt, and FGF signaling. Here, we directly address the role of the relative timing between Wnt and Notch signaling oscillations during PSM patterning. To this end, we developed a new experimental strategy using microfluidics-based entrainment that enables specific control of the rhythm of segmentation clock oscillations. Using this approach, we find that Wnt and Notch signaling are coupled at the level of their oscillation dynamics. Furthermore, we provide functional evidence that the oscillation phase shift between Wnt and Notch signaling is critical for PSM segmentation. Our work hence reveals that dynamic signaling, i.e., the relative timing between oscillatory signals, encodes essential information during multicellular development.


Subject(s)
Body Patterning , Mesoderm/embryology , Receptors, Notch/metabolism , Signal Transduction , Wnt Proteins/metabolism , Animals , Genes, Reporter , Mesoderm/metabolism , Mice , Microfluidics , Somites/embryology , Somites/metabolism
2.
Nat Methods ; 17(6): 629-635, 2020 06.
Article in English | MEDLINE | ID: mdl-32483332

ABSTRACT

The transcriptome contains rich information on molecular, cellular and organismal phenotypes. However, experimental and statistical limitations constrain sensitivity and throughput of genetic screening with single-cell transcriptomics readout. To overcome these limitations, we introduce targeted Perturb-seq (TAP-seq), a sensitive, inexpensive and platform-independent method focusing single-cell RNA-seq coverage on genes of interest, thereby increasing the sensitivity and scale of genetic screens by orders of magnitude. TAP-seq permits routine analysis of thousands of CRISPR-mediated perturbations within a single experiment, detects weak effects and lowly expressed genes, and decreases sequencing requirements by up to 50-fold. We apply TAP-seq to generate perturbation-based enhancer-target gene maps for 1,778 enhancers within 2.5% of the human genome. We thereby show that enhancer-target association is jointly determined by three-dimensional contact frequency and epigenetic states, allowing accurate prediction of enhancer targets throughout the genome. In addition, we demonstrate that TAP-seq can identify cell subtypes with only 100 sequencing reads per cell.


Subject(s)
Clustered Regularly Interspaced Short Palindromic Repeats/genetics , Genome, Human , RNA-Seq/methods , Single-Cell Analysis/methods , Transcriptome/genetics , Humans
3.
Dev Growth Differ ; 64(9): 501-507, 2022 Dec.
Article in English | MEDLINE | ID: mdl-36308491

ABSTRACT

Size of the nucleus, a membrane-bound organelle for DNA replication and transcription in eukaryotic cells, varies to adapt nuclear functions to the surrounding environment. Nuclear size strongly correlates with cytoplasmic size and genomic content. Previous studies using Xenopus laevis have unraveled two modes, cytoplasmic and chromatin-based mechanisms, for controlling nuclear size. However, owing to limited comparative analyses of the mechanisms among eukaryotic species, the contribution of each mechanism in controlling nuclear size has not been comprehensively elucidated. Here, we compared the relative contribution utilizing a cell-free reconstruction system from the cytoplasmic extract of unfertilized eggs of Xenopus tropicalis to that of the sister species X. laevis. In this system, interphase nuclei were reconstructed in vitro from sperm chromatin and increased in size throughout the incubation period. Using extracts from X. tropicalis, growth rate of the reconstructed nuclei was decreased by obstructing the effective cytoplasmic space, decreasing DNA quantity, or inhibiting molecules involved in various cytoplasmic mechanisms. Although these features are qualitatively identical to that shown by the extract of X. laevis, the sensitivities of experimental manipulation for each cellular parameter were different between the extracts from two Xenopus species. These quantitative differences implied that the contribution of each mode to expansion of the nuclear envelope is coordinated in a species-specific manner, which sets the species-specific nuclear size for in vivo physiological function.


Subject(s)
Cell Nucleus , Semen , Animals , Male , Xenopus laevis , Xenopus , Cell Nucleus/physiology , Chromatin , Ovum
4.
Mol Syst Biol ; 16(2): e8664, 2020 02.
Article in English | MEDLINE | ID: mdl-32073727

ABSTRACT

Mechanistic modeling of signaling pathways mediating patient-specific response to therapy can help to unveil resistance mechanisms and improve therapeutic strategies. Yet, creating such models for patients, in particular for solid malignancies, is challenging. A major hurdle to build these models is the limited material available that precludes the generation of large-scale perturbation data. Here, we present an approach that couples ex vivo high-throughput screenings of cancer biopsies using microfluidics with logic-based modeling to generate patient-specific dynamic models of extrinsic and intrinsic apoptosis signaling pathways. We used the resulting models to investigate heterogeneity in pancreatic cancer patients, showing dissimilarities especially in the PI3K-Akt pathway. Variation in model parameters reflected well the different tumor stages. Finally, we used our dynamic models to efficaciously predict new personalized combinatorial treatments. Our results suggest that our combination of microfluidic experiments and mathematical model can be a novel tool toward cancer precision medicine.


Subject(s)
Antineoplastic Agents/administration & dosage , Pancreatic Neoplasms/pathology , Signal Transduction/drug effects , Animals , Antineoplastic Agents/pharmacology , Biopsy , Cell Line, Tumor , Cell Survival/drug effects , Drug Screening Assays, Antitumor , Female , Genetic Heterogeneity , Humans , Logistic Models , Mice , Microfluidic Analytical Techniques , Pancreatic Neoplasms/metabolism , Patient-Specific Modeling , Phosphatidylinositol 3-Kinase/metabolism , Precision Medicine , Proto-Oncogene Proteins c-akt/metabolism , Xenograft Model Antitumor Assays
5.
Small ; 16(9): e1904321, 2020 03.
Article in English | MEDLINE | ID: mdl-31747127

ABSTRACT

Tailoring patient-specific treatments for cancer is necessary in order to achieve optimal results but requires new diagnostic approaches at affordable prices. Microfluidics has immense potential to provide solutions for this, as it enables the processing of samples that are not available in large quantities (e.g., cells from patient biopsies), is cost efficient, provides a high level of automation, and allows the set-up of complex models for cancer studies. In this review, individual solutions in the fields of genetics, circulating tumor cell monitoring, biomarker analysis, phenotypic drug sensitivity tests, and systems providing controlled environments for disease modeling are discussed. An overview on how these early stage achievements can be combined or developed further is showcased, and the required translational steps before microfluidics becomes a routine tool for clinical applications are critically discussed.


Subject(s)
Microfluidics , Neoplasms , Precision Medicine , Humans , Monitoring, Physiologic , Neoplasms/therapy , Neoplastic Cells, Circulating , Precision Medicine/instrumentation , Precision Medicine/methods , Precision Medicine/trends
6.
Anal Chem ; 90(10): 5982-5988, 2018 05 15.
Article in English | MEDLINE | ID: mdl-29688703

ABSTRACT

Partitioning and sorting particles, including molecules, cells and organisms, is an essential prerequisite for a diverse range of applications. Here, we describe a very economical microfluidic platform (built from parts costing about U.S. $6800 for a stand-alone system or U.S. $3700, when mounted on an existing fluorescence microscope connected to a computer) to sort droplets, cells and embryos, based on imaging data. Valves operated by a Braille display are used to open and close microfluidic channels, enabling sorting at rates of >2 Hz. Furthermore, we show microfluidic 8-way sorting for the first time, facilitating the simultaneous separation and collection of objects with diverse characteristics/phenotypes. Due to the high flexibility in the size of objects that can be sorted, the low cost, and the many possibilities enabled by imaging technology, we believe that our approach nicely complements existing FACS and µFACS technology.


Subject(s)
Cell Separation/economics , Drosophila/embryology , Microfluidic Analytical Techniques/economics , Adsorption , Animals , Cell Line, Tumor , Humans , Microfluidic Analytical Techniques/instrumentation , Microscopy, Fluorescence , Particle Size , Surface Properties
8.
Proc Natl Acad Sci U S A ; 109(29): 11570-5, 2012 Jul 17.
Article in English | MEDLINE | ID: mdl-22753519

ABSTRACT

Monoclonal antibodies can specifically bind or even inhibit drug targets and have hence become the fastest growing class of human therapeutics. Although they can be screened for binding affinities at very high throughput using systems such as phage display, screening for functional properties (e.g., the inhibition of a drug target) is much more challenging. Typically these screens require the generation of immortalized hybridoma cells, as well as clonal expansion in microtiter plates over several weeks, and the number of clones that can be assayed is typically no more than a few thousand. We present here a microfluidic platform allowing the functional screening of up to 300,000 individual hybridoma cell clones within less than a day. This approach should also be applicable to nonimmortalized primary B-cells, as no cell proliferation is required: Individual cells are encapsulated into aqueous microdroplets and assayed directly for the release of antibodies inhibiting a drug target based on fluorescence. We used this system to perform a model screen for antibodies that inhibit angiotensin converting enzyme 1, a target for hypertension and congestive heart failure drugs. When cells expressing these antibodies were spiked into an unrelated hybridoma cell population in a ratio of 1:10,000 we observed a 9,400-fold enrichment after fluorescence activated droplet sorting. A wide variance in antibody expression levels at the single-cell level within a single hybridoma line was observed and high expressors could be successfully sorted and recultivated.


Subject(s)
Antibodies, Monoclonal/metabolism , High-Throughput Screening Assays/methods , Hybridomas/metabolism , Microfluidics/methods , Antibody Affinity/physiology , B-Lymphocytes/metabolism , Fluorescence , Peptidyl-Dipeptidase A/metabolism
9.
Lab Chip ; 23(11): 2514-2520, 2023 May 30.
Article in English | MEDLINE | ID: mdl-37199565

ABSTRACT

Crosstalk between fluorescent biomarkers significantly limits the resolution of multispectral fluorescence analysis in real-time droplet-microfluidics applications. The crosstalk is a result of overlapping emission and excitation spectra of different fluorophores in multiplexed analyses. To mitigate this crosstalk, we present a method that modulates multiple laser beams to selectively and sequentially excite the fluorophores by a single beam of a particular wavelength using acousto-optic modulators at a frequency of 0.1 MHz. An FPGA based data acquisition algorithm synchronized with the modulation signal then acquires the emission signals only from the fluorescence channel that corresponds to the excitation wavelength provided in that particular time window. We applied our method for fluorescence-based droplet analysis in microfluidics and demonstrate that the method is able to reduce crosstalk contribution between channels by >97% and can resolve fluorescence populations that are indistinguishable with conventional droplet analysis methods.

10.
Nat Protoc ; 18(4): 1090-1136, 2023 04.
Article in English | MEDLINE | ID: mdl-36707723

ABSTRACT

Droplet microfluidics has revolutionized quantitative high-throughput bioassays and screening, especially in the field of single-cell analysis where applications include cell characterization, antibody discovery and directed evolution. However, droplet microfluidic platforms capable of phenotypic, fluorescence-based readouts and sorting are still mostly found in specialized labs, because their setup is complex. Complementary to conventional FACS, microfluidic droplet sorters allow the screening of cell libraries for secreted factors, or even for the effects of secreted or surface-displayed factors on a second cell type. Furthermore, they also enable PCR-activated droplet sorting for the isolation of genetic material harboring specific markers. In this protocol, we provide a detailed step-by-step guide for the construction of a high-throughput droplet analyzer and sorter, which can be accomplished in ~45 working hours by nonspecialists. The resulting instrument is equipped with three lasers to excite the fluorophores in droplets and photosensors that acquire fluorescence signals in the blue (425-465 nm), green (505-545 nm) and red (580-630 nm) spectrum. This instrument also allows transmittance-activated droplet sorting by analyzing the brightfield light intensity transmitting through the droplets. The setup is validated by sorting droplets containing fluorescent beads at 200 Hz with 99.4% accuracy. We show results from an experiment where droplets hosting single cells were sorted on the basis of increased matrix metalloprotease activity as an application of our workstation in single-cell molecular biology, e.g., to analyze molecular determinants of cancer metastasis.


Subject(s)
Antibodies , Microfluidics , Microfluidics/methods , Fluorescent Dyes
11.
Cell Rep Methods ; 3(5): 100478, 2023 May 22.
Article in English | MEDLINE | ID: mdl-37323570

ABSTRACT

Fluorescence-activated droplet sorting (FADS) is a widely used microfluidic technique for high-throughput screening. However, it requires highly trained specialists to determine optimal sorting parameters, and this results in a large combinatorial space that is challenging to optimize systematically. Additionally, it is currently challenging to track every single droplet within a screen, leading to compromised sorting and "hidden" false-positive events. To overcome these limitations, we have developed a setup in which the droplet frequency, spacing, and trajectory at the sorting junction are monitored in real time using impedance analysis. The resulting data are used to continuously optimize all parameters automatically and to counteract perturbations, resulting in higher throughput, higher reproducibility, increased robustness, and a beginner-friendly character. We believe this provides a missing piece for the spreading of phenotypic single-cell analysis methods, similar to what we have seen for single-cell genomics platforms.


Subject(s)
Microfluidic Analytical Techniques , Microfluidics , Microfluidics/methods , Reproducibility of Results , Genomics , Single-Cell Analysis/methods
12.
Lab Chip ; 23(16): 3704-3715, 2023 08 08.
Article in English | MEDLINE | ID: mdl-37483015

ABSTRACT

Key to our ability to increase recombinant protein production through secretion is a better understanding of the pathways that interact to translate, process and export mature proteins to the surrounding environment, including the supporting cellular machinery that supplies necessary energy and building blocks. By combining droplet microfluidic screening with large-scale CRISPR libraries that perturb the expression of the majority of coding and non-coding genes in S. cerevisiae, we identified 345 genes for which an increase or decrease in gene expression resulted in increased secretion of α-amylase. Our results show that modulating the expression of genes involved in the trafficking of vesicles, endosome to Golgi transport, the phagophore assembly site, the cell cycle and energy supply improve α-amylase secretion. Besides protein-coding genes, we also find multiple long non-coding RNAs enriched in the vicinity of genes associated with endosomal, Golgi and vacuolar processes. We validated our results by overexpressing or deleting selected genes, which resulted in significant improvements in α-amylase secretion. The advantages, in terms of precision and speed, inherent to CRISPR based perturbations, enables iterative testing of new strains for increased protein secretion.


Subject(s)
Saccharomyces cerevisiae Proteins , Saccharomyces cerevisiae , Saccharomyces cerevisiae/genetics , Saccharomyces cerevisiae/metabolism , Saccharomyces cerevisiae Proteins/genetics , Saccharomyces cerevisiae Proteins/metabolism , Amylases/metabolism , Microfluidics , alpha-Amylases/genetics , alpha-Amylases/metabolism
13.
Trends Cell Biol ; 32(11): 947-961, 2022 11.
Article in English | MEDLINE | ID: mdl-35577671

ABSTRACT

Engineering and computational advances have opened many new avenues in cancer research, particularly when being exploited in interdisciplinary approaches. For example, the combination of microfluidics, novel sequencing technologies, and computational analyses has been crucial to enable single-cell assays, giving a detailed picture of tumor heterogeneity for the very first time. In a similar way, these 'tech' disciplines have been elementary for generating large data sets in multidimensional cancer 'omics' approaches, cell-cell interaction screens, 3D tumor models, and tissue level analyses. In this review we summarize the most important technology and computational developments that have been or will be instrumental for transitioning classical cancer research to a large data-driven, high-throughput, high-content discipline across all biological scales.


Subject(s)
Neoplasms , Computational Biology/methods , Humans , Neoplasms/genetics , Technology
14.
Cell Rep Methods ; 2(1): None, 2022 01 24.
Article in English | MEDLINE | ID: mdl-35118437

ABSTRACT

We report a droplet microfluidic method to target and sort individual cells directly from complex microbiome samples and to prepare these cells for bulk whole-genome sequencing without cultivation. We characterize this approach by recovering bacteria spiked into human stool samples at a ratio as low as 1:250 and by successfully enriching endogenous Bacteroides vulgatus to the level required for de novo assembly of high-quality genomes. Although microbiome strains are increasingly demanded for biomedical applications, a vast majority of species and strains are uncultivated and without reference genomes. We address this shortcoming by encapsulating complex microbiome samples directly into microfluidic droplets and amplifying a target-specific genomic fragment using a custom molecular TaqMan probe. We separate those positive droplets by droplet sorting, selectively enriching single target strain cells. Finally, we present a protocol to purify the genomic DNA while specifically removing amplicons and cell debris for high-quality genome sequencing.


Subject(s)
Gastrointestinal Microbiome , Microbiota , Humans , Gastrointestinal Microbiome/genetics , Microfluidics/methods , Genomics , Microbiota/genetics , Sequence Analysis, DNA
15.
Nat Protoc ; 17(12): 2920-2965, 2022 12.
Article in English | MEDLINE | ID: mdl-36261631

ABSTRACT

Droplet microfluidics is a powerful tool for a variety of biological applications including single-cell genetics, antibody discovery and directed evolution. All these applications make use of genetic libraries, illustrating the difficulty of generating chemically distinct droplets for screening applications. This protocol describes our Braille Display valving platform for on-demand generation of droplets with different chemical contents (16 different reagents and combinations thereof), as well as sorting droplets with different chemical properties, on the basis of fluorescence signals. The Braille Display platform is compact, versatile and cost efficient (only ~US$1,000 on top of a standard droplet microfluidics setup). The procedure includes manufacturing of microfluidic chips, assembly of custom hardware, co-encapsulation of cells and drugs into droplets, fluorescence detection of readout signals and data analysis using shared, freely available LabVIEW and Python packages. As a first application, we demonstrate the complete workflow for screening cancer cell drug sensitivities toward 74 conditions. Furthermore, we describe here an assay enabling the normalization of the observed drug sensitivity to the number of cancer cells per droplet, which additionally increases the robustness of the system. As a second application, we also demonstrate the sorting of droplets according to enzymatic activity. The drug screening application can be completed within 2 d; droplet sorting takes ~1 d; and all preparatory steps for manufacturing molds, chips and setting up the Braille controller can be accomplished within 1 week.


Subject(s)
Biological Assay , Microfluidics , Microfluidics/methods , Cell Movement
16.
Lab Chip ; 10(10): 1302-7, 2010 May 21.
Article in English | MEDLINE | ID: mdl-20445884

ABSTRACT

Droplet-based microfluidic systems allow biological and chemical reactions to be performed on a drastically decreased scale. However, interfacing the outside world with such systems and generating high numbers of microdroplets of distinct chemical composition remain challenging. We describe here an automated system in which arrays of chemically distinct plugs are generated from microtiter plates. Each array can be split into multiple small-volume copies, thus allowing several screens of the same library. The system is fully compatible with further on-chip manipulation(s) and allows monitoring of individual plugs over time (e.g. for recording reaction kinetics). Hence the technology eliminates several bottlenecks of current droplet-based microfluidic systems and should open the way for (bio-)chemical and cell-based screens.


Subject(s)
Drug Evaluation, Preclinical/instrumentation , Microfluidic Analytical Techniques , Automation , Coumarins/pharmacology , Dose-Response Relationship, Drug , Enzyme Inhibitors/pharmacology , Kinetics , beta-Galactosidase/antagonists & inhibitors , beta-Galactosidase/metabolism
17.
J Am Chem Soc ; 131(18): 6492-7, 2009 May 13.
Article in English | MEDLINE | ID: mdl-19378999

ABSTRACT

Nucleic acid-templated reactions leading to a fluorescent product represent an attractive strategy for the detection and imaging of cellular nucleic acids. Herein we report the use of a Staudinger reaction to promote the reduction of profluorescent azidorhodamine. The use of two cell-permeable GPNA probes, one labeled with the profluorescent azidorhodamine and the other with trialkylphosphine, enabled the detection of the mRNA encoding O-6-methylguanine-DNA methyltransferase in intact cells.


Subject(s)
Cells/cytology , Molecular Probe Techniques , RNA, Messenger/analysis , Rhodamines , Cell Line , Cells/chemistry , DNA Probes , Diagnostic Imaging/methods , Fluorescent Dyes , Humans , O(6)-Methylguanine-DNA Methyltransferase/analysis
18.
J Antimicrob Chemother ; 64(1): 62-8, 2009 Jul.
Article in English | MEDLINE | ID: mdl-19401303

ABSTRACT

OBJECTIVES: To develop a high throughput screening-compatible assay for the selection of species-specific antibiotics that do not harm human cells. METHODS: Staphylococcus aureus and human reporter cells continuously generating a fluorescence signal were competitively co-cultivated. The fluorescence signals were determined in the presence and absence of the specific antibiotic streptomycin and the toxic compound sodium azide. The results were compared with a standard cfu assay. RESULTS: In the absence of an effective antibiotic, S. aureus outgrew the human reporter cells and thus abolished the fluorescence signal. Conversely, the addition of streptomycin resulted in the growth of the reporter cells and a strong fluorescence signal. When sodium azide was added instead of streptomycin, only a very low background signal was obtained indicating toxicity and damage to the human reporter cells. The assay proved to be highly reliable (Z-factor >0.9) and high fluorescence signals correctly correlated with the efficient inhibition of S. aureus, as determined in comparative cfu assays. CONCLUSIONS: In contrast to conventional cfu assays, the co-cultivation system allows the effects of a drug candidate on pathogens and human cells to be monitored simultaneously. Cytotoxic compounds can, therefore, be quickly ruled out during a primary screen. The nature of the screen also enables effective antibiotics to be identified without engineering the target pathogen to yield a fluorescence signal.


Subject(s)
Anti-Bacterial Agents/pharmacology , Anti-Bacterial Agents/toxicity , Drug Evaluation, Preclinical/methods , Staphylococcus aureus/drug effects , Cell Line , Coculture Techniques/methods , Colony Count, Microbial , Humans , Sodium Azide/toxicity , Streptomycin/pharmacology
19.
Chem Biol ; 15(5): 427-37, 2008 May.
Article in English | MEDLINE | ID: mdl-18482695

ABSTRACT

High-throughput, cell-based assays require small sample volumes to reduce assay costs and to allow for rapid sample manipulation. However, further miniaturization of conventional microtiter plate technology is problematic due to evaporation and capillary action. To overcome these limitations, we describe droplet-based microfluidic platforms in which cells are grown in aqueous microcompartments separated by an inert perfluorocarbon carrier oil. Synthesis of biocompatible surfactants and identification of gas-permeable storage systems allowed human cells, and even a multicellular organism (C. elegans), to survive and proliferate within the microcompartments for several days. Microcompartments containing single cells could be reinjected into a microfluidic device after incubation to measure expression of a reporter gene. This should open the way for high-throughput, cell-based screening that can use >1000-fold smaller assay volumes and has approximately 500x higher throughput than conventional microtiter plate assays.


Subject(s)
Caenorhabditis elegans/cytology , Microfluidics/instrumentation , Animals , Emulsions , Humans , Miniaturization
20.
Med Sci (Paris) ; 25(6-7): 627-32, 2009.
Article in French | MEDLINE | ID: mdl-19602361

ABSTRACT

The combination of microfluidic manipulation of emulsion droplets and in vitro compartmentalization offers a means to parallelize biological and chemical assays in droplets. These droplets behave as independent microreactors that are produced, actuated and analyzed at rates of the order of 1000 droplets per seconds providing tools to parallelize assays on small volumes (pL to nL range) for high-throughput -screening: the throughput of the assays performed in droplets is 1000 times larger than the throughput of existing technologies, based on micromanipulation of liquid in microtitre plates by robotic devices. The droplet-based microfluidic technology enables controlled manipulation, analysis and sorting of cells, genes and macromolecules based on their enzymatic activities, as well as chemical compounds based on their activity on biological targets. The integration of microfluidic systems for a series of complex individual operations on droplets could offer a solution to the miniaturization and automation of biological assays, combined with a decrease of the assay volumes and an increase of throughput, going beyond the capacities of conventional screening systems.


Subject(s)
Biology/trends , Emulsions/chemistry , Microfluidics/methods , Biology/methods , Miniaturization/methods , Sensitivity and Specificity , Technology/methods , Technology/trends
SELECTION OF CITATIONS
SEARCH DETAIL